Crescent Biopharma, Inc. (CBIO) is a biotechnology company listed on NASDAQ.
Latest reported CBIO revenue for 2026-06-30 was $1.0M. Net income was -$48.1M. Revenue was up 0.0% from 2026-03-31 to 2026-06-30. CBIO currently screens at market cap $491.3M.
Use this CBIO page for company research — sector, financials, and the latest filing takeaway — not a live tape. The session quote (last, range, volume) lives on the CBIO quote page. Cached 10-K, 10-Q, 8-K, and Form 4 exhibits are on the CBIO SEC filings page. Lician reads the product cache first so this HTML stays unique to Crescent Biopharma, Inc. even when a live quote feed is slow.
Latest cached year on this hub. Full CBIO income, balance, and cash tables.